BIO-RAD LABORATORIES, INC.

For the period ended Sep 30, 2025. Filed Oct 29, 2025.

About this filing

A company's report for each of its first three quarters. The financial statements are not audited. It shows how the business has moved since the last annual report, and what management says changed.

Sep 30, 2025 · Filed Oct 29, 2025

BIO-B$389.98+2.8%Stored close · as of Nov 9, 2026

Extracted filing text, with the paragraph anchors used by the comparison.

See the whole filing, with its images and exhibits

Contents

Condensed Consolidated Statements of Income (Loss)

(In millions, except number of shares, which are reflected in thousands, and per share data)

(Unaudited)

Three Months Ended · Nine Months Ended
	September 30,		September 30,
	2025	2024	2025	2024
Net sales	$653.0	$649.7	$1,890.0	$1,899.0
Cost of goods sold	309.6	293.8	895.3	862.0
Gross profit	343.4	355.9	994.7	1,037.0
Selling, general and administrative expense	206.8	200.4	623.3	610.0
Research and development expense	71.3	91.0	205.3	216.3
Income from operations	65.3	64.5	166.1	210.7
Interest expense	12.3	12.1	36.9	36.7
Foreign currency exchange (gains) losses, net	(2.9)	1.6	(4.5)	(2.0)
(Gains) losses from change in fair market value of equity securities and loan receivable	495.3	(792.9)	129.1	1,680.3
Other income, net	(8.3)	(17.9)	(61.7)	(70.7)
Income (loss) before income taxes	(431.1)	861.6	66.3	(1,433.6)
Benefit from (provision for) income taxes	89.2	(208.4)	(26.4)	305.2
Net income (loss)	$(341.9)	$653.2	$39.9	$(1,128.4)
Basic earnings (loss) per share:
Net income (loss) per basic share	$(12.70)	$23.37	$1.46	$(39.89)
Weighted average common shares - basic	26,923	27,949	27,359	28,286
Diluted earnings (loss) per share:
Net income (loss) per diluted share	$(12.70)	$23.34	$1.46	$(39.89)
Weighted average common shares - diluted	26,923	27,985	27,369	28,286

ContentsView on SEC.gov

The text of this filing, as the company filed it with the SEC, without its images or exhibits. This is not investment advice.